Method of using CT/MRI dual modality contrast agent

US9339562B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9339562-B2
Application numberUS-201113070025-A
CountryUS
Kind codeB2
Filing dateMar 23, 2011
Priority dateSep 28, 2010
Publication dateMay 17, 2016
Grant dateMay 17, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nanoparticles are used as a contrast agent for magnetic resonance imaging and computed tomography. Each of the nanoparticles includes a metal alloy core and a plurality of hydrophilic molecules covalently bound to the surface of the metal alloy core. Also disclosed is a method for using the contrast agent.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of imaging a subject comprising: administering to a subject an effective amount of a contrast agent, scanning the subject with a magnetic resonance device and an X-ray computed tomography device, and generating a magnetic resonance image and a computed tomography image of the subject from the scanning, wherein the contrast agent contains (i) nanoparticles, each of which includes a metal alloy core and a plurality of hydrophilic molecules covalently bound to the metal alloy of the metal alloy core, the metal alloy core having an average diameter of 1-25 nm and composed of a metal alloy containing a first metal and a second metal, in which the first metal has an X-ray absorption coefficient of 6-11 cm 2 /g at 50 kiloelectron volt and the second metal is paramagnetic, and (ii) an aqueous solvent in which the nanoparticles are dispersed, wherein the nanoparticles are prepared by sonicating a mixture of the metal alloy core and the plurality of hydrophilic molecules. 2. The method of claim 1 , wherein the first metal is selected from the group consisting of Pt, Pd, Au, and Ag; and the second metal is selected from the group consisting of Fe, Co, Ni, and Mn. 3. The method of claim 2 , wherein the first metal is Pt and the second metal is Fe. 4. The method of claim 1 , wherein each of the hydrophilic molecules contains a sulfhydryl group. 5. The method of claim 4 , wherein the first metal is selected from the group consisting of Pt, Pd, Au, and Ag; and the second metal is selected from the group consisting of Fe, Co, Ni, and Mn. 6. The method of claim 1 , wherein the first metal is Pt and the second metal is Fe. 7. The method of claim 4 , wherein each of the hydrophilic molecules contains a targeting moiety. 8. The method of claim 7 , wherein the first metal is Pt, the second metal is Fe, and the targeting moiety is an antibody. 9. The method of claim 1 , wherein the metal alloy core has an average diameter of 2-4 nm; the first metal is selected from the group consisting of Pt, Pd, Au, and Ag; and the second metal is selected from the group consisting of Fe, Co, Ni, and Mn. 10. The method of claim 9 , wherein each of the hydrophilic molecules contains a sulfhydryl group. 11. The method of claim 10 , wherein each of the hydrophilic molecules further contains a targeting moiety that is an antibody. 12. The method of claim 11 , wherein the first metal is Pt and the second metal is Fe. 13. The method of claim 1 , wherein the metal alloy core has an average diameter of 5-7 nm; the first metal is selected from the group consisting of Pt, Pd, Au, and Ag; and the second metal is selected from the group consisting of Fe, Co, Ni, and Mn. 14. The method of claim 13 , wherein each of the hydrophilic molecules contains a sulfhydryl group. 15. The method of claim 14 , wherein each of the hydrophilic molecules further contains a targeting moiety that is an antibody. 16. The method of claim 15 , wherein the first metal is Pt and the second metal is Fe. 17. The method of claim 1 , wherein the metal alloy core has an average diameter of 11-15 nm; the first metal is selected from the group consisting of Pt, Pd, Au, and Ag; and the second metal is selected from the group consisting of Fe, Co, Ni, and Mn. 18. The method of claim 17 , wherein each of the hydrophilic molecules contains a sulfhydryl group. 19. The method of claim 18 , wherein each of the hydrophilic molecules further contains a targeting moiety that is an antibody. 20. The method of claim 19 , wherein the first metal is Pt and the second metal is Fe.

Assignees

Inventors

Classifications

  • Nanosized particles · CPC title

  • Complex form nanoparticles, e.g. prism, pyramid, octahedron · CPC title

  • Operations & Transport · mapped topic

  • Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

  • Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9339562B2 cover?
Nanoparticles are used as a contrast agent for magnetic resonance imaging and computed tomography. Each of the nanoparticles includes a metal alloy core and a plurality of hydrophilic molecules covalently bound to the surface of the metal alloy core. Also disclosed is a method for using the contrast agent.
Who is the assignee on this patent?
Chen Chia-Chun, Shieh Dar-Bin, Chou Shang-Wei, and 5 more
What technology area does this patent fall under?
Primary CPC classification A61K49/0428. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).